Skip to main content
logo
Korro Bio, Inc. (KRRO)
NASDAQ: KRRO · Real-Time Price · USD
9.64
-0.07 (-0.72%)
Oct 2, 2026, 4:00 PM EDT - Market closed

Korro Bio Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
14275357383--
Market Cap Growth
-65.57%-78.85%-6.96%---
Enterprise Value
4618229578--
Last Close Price
9.648.0138.0747.93--

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
59.5911.80157.04---
PB Ratio
1.371.472.222.26--
P/TBV Ratio
1.381.472.222.26--

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
19.422.76100.98---

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.410.850.280.200.05-
Net Debt / Equity Ratio
-0.93-0.81-0.74-0.78-0.80-0.97
Net Debt / EBITDA Ratio
1.290.501.341.640.923.50
Net Debt / FCF Ratio
1.400.531.521.770.893.24
Asset Turnover
0.010.040.01---
Quick Ratio
9.116.388.548.536.3523.95
Current Ratio
9.556.908.798.876.5624.20
Return on Equity (ROE)
-97.69%-110.70%-50.60%-69.16%-62.24%-
Return on Assets (ROA)
-27.95%-32.14%-25.65%-35.77%-36.63%-
Return on Capital Employed (ROCE)
-51.00%-86.00%-43.50%-41.80%-90.70%-28.90%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-75.13%-155.45%-23.43%-21.18%--
FCF Yield
-48.09%-104.83%-21.86%-19.60%--
Buyback Yield / Dilution
-28.33%-5.32%-483.30%-499.32%94.26%-
SEC Filings: 10-K · 10-Q